These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2973752)

  • 1. Prostatic carcinoma with lung metastases in a former bagasse worker; LH-RH analogs as an alternative therapy.
    Comaru-Schally AM; Kushner DS
    Am J Med Sci; 1988 Nov; 296(5):348-53. PubMed ID: 2973752
    [No Abstract]   [Full Text] [Related]  

  • 2. Clearance of lung metastases of prostate carcinoma after treatment with LH-RH agonist.
    Comaru-Schally AM; Ramalho A; Leitao PR; Schally AV
    Lancet; 1984 Aug; 2(8397):281-2. PubMed ID: 6146827
    [No Abstract]   [Full Text] [Related]  

  • 3. Metastatic carcinoma of the prostate in both testes of patients treated with LH-RH analogues.
    Hadjissotiriou GG; Papadopoulos S; Rebelakos A
    Br J Urol; 1992 Jun; 69(6):657-9. PubMed ID: 1386273
    [No Abstract]   [Full Text] [Related]  

  • 4. LH-RH agonist monotherapy in patients with carcinoma of the prostate and reflections on the so-called total androgen blockade.
    Jacobi GH
    Recent Results Cancer Res; 1990; 118():174-85. PubMed ID: 2146724
    [No Abstract]   [Full Text] [Related]  

  • 5. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Schally AV; Redding TW
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.
    Tolis G; Ackman D; Stellos A; Mehta A; Labrie F; Fazekas AT; Comaru-Schally AM; Schally AV
    Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1658-62. PubMed ID: 6461861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An oriented phase-II trial of D-Trp6-LH-RH in patients with prostatic carcinoma.
    Mathé G; Vo Van ML; Duchier J; Misset JL; Morin P; Keiling R; Schwarzenberg L; Kerbrat P; Achille E; Tronc JC
    Med Oncol Tumor Pharmacother; 1984; 1(2):119-22. PubMed ID: 6242478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-Trp-6-LH-RH treatment of advanced prostatic cancer.
    Boccardo F; Giuliani L; Santi L
    Lancet; 1986 Mar; 1(8481):621. PubMed ID: 2869332
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of prostatic cancer with an LH-RH agonist: the D Trp6 LH-RH. Preliminary results in 30 cases].
    Steg A; Chiche R; Boccon-Gibod L; Debré B; Duchier J; Schally AV
    Ann Urol (Paris); 1984 Dec; 18(6):388-92. PubMed ID: 6241820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of advanced prostatic cancer with a gonadorelin agonist, dTrp6 LHRH. 41 cases].
    Steg A; Chiche R; Boccon-Gibod L; Debré B
    Presse Med; 1985 Nov; 14(40):2045-8. PubMed ID: 2934695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of advanced prostatic carcinoma with D-Trp-6-LH-RH.
    Gonzalez-Barcena D; Perez-Sanchez P; Ureta-Sanchez S; Berea Dominguez H; Graef-Sanchez A; Becerril Morales M; Comaru-Schally AM; Schally AV
    Prostate; 1985; 7(1):21-30. PubMed ID: 2934692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotropin-releasing hormone analogs and prostatic cancer.
    Swanson LJ; Seely JH; Garnick MB
    Crit Rev Oncol Hematol; 1988; 8(1):1-26. PubMed ID: 2964939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contribution to studies on the treatment of cancer of the prostate with D-Trp6-LH-RH].
    Marcellino LR; Campanella A; Bandini M
    Biomed Pharmacother; 1987; 41(9-10):468-72. PubMed ID: 2968123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of carcinoma of the prostate with analogs of LHRH].
    Rubio Herrera MA; Calle Fernández JR
    Rev Clin Esp; 1986 Nov; 179(8):407-11. PubMed ID: 2951782
    [No Abstract]   [Full Text] [Related]  

  • 15. Receptors for prolactin, somatostatin, and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin.
    Kadar T; Redding TW; Ben-David M; Schally AV
    Proc Natl Acad Sci U S A; 1988 Feb; 85(3):890-4. PubMed ID: 2893378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An analog of gonadoliberin in the treatment of prostatic carcinoma].
    Mathé G; Schally AV; Vo Van ML; Duchier J; Misset JL; Keiling R
    Presse Med; 1984 Jun; 13(23):1443-5. PubMed ID: 6233591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dramatic aggravation of prostatic cancer at the onset of treatment with an LHRH agonist].
    Boumier P; Koeger AC; Camus JP
    Presse Med; 1985 May; 14(21):1200-1. PubMed ID: 3158996
    [No Abstract]   [Full Text] [Related]  

  • 18. Disease flare induced by luteinising hormone releasing hormone analogues in cancer patients.
    Deghenghi R; Misset JL
    Lancet; 1984 Jun; 1(8389):1302. PubMed ID: 6145013
    [No Abstract]   [Full Text] [Related]  

  • 19. [Advanced cancer of the prostate. Treatment with an LH-RH agonist, D-Trp-6-LH-RH].
    Mathé G; Misset JL; Vovan ML; Machover D
    Bull Cancer; 1986; 73(1):31-5. PubMed ID: 2430652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer.
    Waxman J; Man A; Hendry WF; Whitfield HN; Besser GM; Tiptaft RC; Paris AM; Oliver RT
    Br Med J (Clin Res Ed); 1985 Nov; 291(6506):1387-8. PubMed ID: 2933122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.